Overview

A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

This study compares the pharmacokinetics characteristics of a single oral intake of an imported PROBUCOL tablet(Lorelco)(1*250mg/tablet) with a marketed PROBUCOL tablet (Chang Tai)(1*250mg/tablet) in healthy male volunteers to demonstrate they are bioequivalent.

Phase:

N/A

Details

Lead Sponsor:

Otsuka Beijing Research Institute

Treatments:

Probucol